Uncoupling caspase 8-mediated-apotosis from caspase 8-mediated-inflammation in glaucoma.
Uncoupling caspase 8-mediated-apotosis from caspase 8-mediated-inflammation in glaucoma.
批准号:
9919567
负责人:
MEREDITH GREGORY-KSANDER
金额:
$24.63万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2022-04-30
关键词:
Anti-Inflammatory AgentsApoptosisApoptoticAxonBAX geneBlindnessCASP3 geneCASP8 geneCCL2 geneCD95 AntigensCRISPR/Cas technologyCell DeathCellsCessation of lifeChronicChronic DiseaseCleaved cellComplexDataDevelopmentEtanerceptEventExperimental ModelsGlaucomaGoalsGrantInduction of ApoptosisInflammationInflammation MediatorsInflammatoryInterleukin-1 betaInterleukin-6LaboratoriesLigand BindingLinkLiteratureMediatingMicrogliaMicrospheresMinocyclineModelingMolecularMusMutant Strains MiceOptic DiskOptic NervePathway interactionsPharmaceutical PreparationsPlayPoint MutationPublishingResearchRetinaRetinal Ganglion CellsRoleSignal PathwaySignal TransductionSiteTestingTumor Necrosis Factor Ligand Superfamily Member 6Workaxon injuryaxonal degenerationchemokinecytokinehuman modelmouse modelneuronal cell bodyneuroprotectionneurotoxicnovel strategiespreventretinal apoptosis
中文摘要
青光眼的一个重要的未解问题是视网膜神经节细胞(RGCs)的凋亡是否与青光眼相关
英文摘要
One important unanswered question in glaucoma is whether apoptosis of retinal ganglion cells (RGCs) and
axon degeneration are two separate events mediated by molecularly distinct pathways, or whether they are
linked and triggered through a common pathway. Answering this question is critical to developing effective
neuroprotective therapies that protect both axons and RGC somas. In support of the idea there are two distinct
pathways that mediate axon degeneration and RGC apoptosis, it was demonstrated that deletion of the pro-
apoptotic BAX gene blocked apoptosis of RGCs in a mouse model of glaucoma, but did not prevent axon
degeneration. There is accumulating evidence that axon degeneration is triggered by axon damage in the optic
nerve head, which precedes RGC apoptosis and is linked to microglial activation and neurotoxic inflammation.
Therefore, it is possible that blocking inflammation could prevent axon degeneration and subsequent death of
RGCs, leaving open the possibility that there is a shared pathway linking axon degeneration and RGC
apoptosis. In support of the idea that inflammation may be the shared pathway that links axon degeneration
and RGC apoptosis, our laboratory demonstrated previously that blocking the Fas/Fas ligand (FasL) signaling
pathway prevents axon degeneration and RGC apoptosis in both inducible and chronic mouse models of
glaucoma and this protection coincided with an inhibition of microglia activation and induction of inflammatory
mediators. However, since Fas triggers apoptotic and inflammatory pathways, the question remains as to
whether blocking inflammation alone would prevent axon degeneration and subsequent RGC apoptosis. The
challenge to resolving this issue is the inability to uncouple Fas-mediated inflammation from Fas-mediated
apoptosis. However, Fas signaling requires activation of caspase-8 for both apoptosis and inflammation and
recent studies examining the molecular mechanism of caspase-8 activation discovered an additional auto-
cleavage step that is required for the induction of caspase-8-mediated apoptosis but not required for induction
of caspase-8 mediated inflammation. Using this information, a mutant mouse was created (Casp8DA/DA) in
which a point mutation in the auto-cleavage site blocked caspase-8-mediated apoptosis, but did not block
caspase-8-mediated inflammation. We will use these mice to definitively determine how caspase-8-mediated
inflammation and/or apoptosis triggers axon degeneration and RGC apoptosis in glaucoma. We hypothesize
that elevated IOP triggers caspase-8-mediated inflammation that acts as a common pathway triggering axon
degeneration and RGC apoptosis. This hypothesis will be tested in two aims: (1) Determine whether caspase-
8-mediated apoptosis contributes to axon degeneration and death of RGCs in a microbead-induced mouse
model of glaucoma and (2) Demonstrate that Fas-mediated activation of microglia mediates neurotoxic
inflammation, axon degeneration, and death of RGCs in the microbead-induced mouse model of glaucoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
-
批准号:10374484
-
项目类别:
-
资助金额:$61.96万
-
财政年份:2022
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
-
批准号:10867990
-
项目类别:
-
资助金额:$4.36万
-
财政年份:2022
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
-
批准号:10550147
-
项目类别:
-
资助金额:$60.02万
-
财政年份:2022
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of the neuroinflammatory response in autoimmune uveitis
-
批准号:10320063
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2021
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of the neuroinflammatory response in autoimmune uveitis
-
批准号:10115860
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2021
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of the neuroinflammatory response in autoimmune uveitis
-
批准号:10527371
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2021
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of vascular leakage in age related macular degeneration
-
批准号:8385057
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2012
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of vascular leakage in age related macular degeneration
-
批准号:8534134
-
项目类别:
-
资助金额:$21.67万
-
财政年份:2012
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
-
批准号:8237645
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2011
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
-
批准号:8389866
-
项目类别:
-
资助金额:$46.08万
-
财政年份:2011
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
-
批准号:8581345
-
项目类别:
-
资助金额:$47.53万
-
财政年份:2011
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:7534765
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:6857036
-
项目类别:
-
资助金额:$41.7万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:7342074
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:6986096
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:7171789
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Regulation of Ocular Innate Immunity
-
批准号:6525174
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2002
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Regulation of Ocular Innate Immunity
-
批准号:6641246
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2002
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Regulation of Ocular Innate Immunity
-
批准号:6405260
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2001
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Role of Toxins in Endophthalmitis
-
批准号:8288200
-
项目类别:
-
资助金额:$41.7万
-
财政年份:1989
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: